1198444
1206367
1206379
H3D Vision & Mission
Vision: To be the leading organisation for integrated drug discovery and development on the African continent Mission: Discover and develop innovative, life saving medicines For African patients Through excellence in interdisciplinary,...
H3D Facilities
Facilities H3D has state of the art laboratory equipment and access to modern instrumentation housed in the Department of Chemistry, the Department of Clinical Pharmacology and the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT...
R&D Environment
UCT offers a truly integrated environment for translational research in communicable and non communicable diseases afflicting people in Africa. It has both the infrastructure as well as numerous groups working on pre-clinical and clinical research...
Home > Home

News

Friday, 22 June 2018
PIONEER OF WORLD CLASS DRUG DISCOVERY CENTRE IN AFRICA IS NAMED ONE OF FORTUNE’S 50 WORLD’S GREATEST LEADERS FOR 2018

The founder and director of Africa’s first integrated drug discovery centre, Professor Kelly Chibale, has been named as one of Fortune magazine’s World’s Greatest Leaders for 2018.

Chibale, whose H3D centre at the University of Cape Town pioneers world-class drug discovery in Africa, has also become known for his pivotal work on malaria.

Publication Date:
Monday, April 23, 2018 - 14:00
THE WORLD'S 50 GREATEST LEADERS

45. Kelly Chibale

Scientist, South Africa

In much of Africa, the infrastructure to support scientific research is sorely lacking. But Chibale is working to change that. The Zambian chemist has built H3D, Africa’s first integrated drug discovery center, at the University of Cape Town. His team now includes more than 90 researchers; they work out of state-of-the-art facilities thanks to partnerships with the Gates Foundation, Novartis, and South Africa’s government. H3D already has a potential drug for ­malaria in human trials.

Publication Date:
Thursday, April 19, 2018 - 18:00
Project team
MERCK, UNIVERSITY OF CAPE TOWN AND MEDICINES FOR MALARIA VENTURE JOIN FORCES TO FEED THE ANTIMALARIAL PIPELINE
Merck, the University of Cape Town and Medicines for Malaria Venture create an antimalarial drug discovery platform, strengthening their partnership in the fight against malaria The partners will collaborate to build research capacity in Africa
Publication Date:
Thursday, April 19, 2018 - 15:00
EXPRESSO INTERVIEW

Expresso Show

We chat with Professor Kelly Chibale from the South African Medical Research Council to get an update on Malaria and which hotspots to watch out for over the festive season.

 

Publication Date:
Wednesday, February 21, 2018 - 18:00

Pages